Biora Therapeutics Stock Alpha and Beta Analysis
| BIOR Stock | USD 1.67 0.04 2.45% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biora Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biora Therapeutics over a specified time horizon. Remember, high Biora Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biora Therapeutics' market risk premium analysis include:
Beta 1.67 | Alpha (2.05) | Risk 6.4 | Sharpe Ratio (0.30) | Expected Return (1.94) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Biora |
Biora Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biora Therapeutics market risk premium is the additional return an investor will receive from holding Biora Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biora Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biora Therapeutics' performance over market.| α | -2.05 | β | 1.67 |
Biora Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Biora Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Biora Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Biora Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Biora Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biora Therapeutics shares will generate the highest return on investment. By understating and applying Biora Therapeutics stock market price indicators, traders can identify Biora Therapeutics position entry and exit signals to maximize returns.
Biora Therapeutics Return and Market Media
The median price of Biora Therapeutics for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 is 5.34 with a coefficient of variation of 35.09. The daily time series for the period is distributed with a sample standard deviation of 1.7, arithmetic mean of 4.84, and mean deviation of 1.47. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | BIOR Stock Earnings Biora Therapeutics Beats EPS for Q1 2024 - MSN | 09/18/2024 |
2 | Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium | 10/07/2024 |
3 | Biora Therapeutics to Reveal 00-Size BioJet Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting | 10/14/2024 |
4 | Biora Therapeutics stock falls as it looks to raise 3M via direct offering | 10/29/2024 |
5 | Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update | 11/07/2024 |
6 | Highbridge Capital Managements Strategic Acquisition of Biora Therapeutics Shares | 11/14/2024 |
7 | Wainwright lifts Biora Therapeutics stock target, keeps Buy rating on Q3 report | 11/18/2024 |
About Biora Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biora or other stocks. Alpha measures the amount that position in Biora Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 6.69E-4 | 5.94E-4 | Price To Sales Ratio | 53.2K | 55.9K |
Biora Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Biora Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biora Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Biora Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Biora Therapeutics. Please utilize our Beneish M Score to check the likelihood of Biora Therapeutics' management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Biora Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Biora Stock Analysis
When running Biora Therapeutics' price analysis, check to measure Biora Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biora Therapeutics is operating at the current time. Most of Biora Therapeutics' value examination focuses on studying past and present price action to predict the probability of Biora Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biora Therapeutics' price. Additionally, you may evaluate how the addition of Biora Therapeutics to your portfolios can decrease your overall portfolio volatility.